JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 9 No. 9, September 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Dextromethorphan Abuse Among Youth

Recent letters to the Archives of Family Medicine have addressed the abuse potential and dangers of dextromethorphan (DM), a common ingredient in over-the-counter (OTC) medications.1-2 Abuse of DM among youth has been reported since the 1960s,3 and clinical reports continue to document this problem,4 but the prevalence of DM abuse is unclear. Family physicians may be interested in the results of a survey we administered (with active parental consent) to a sample of 376 in 4th- through 12th-grade students at 5 public schools (about 40% of all students) in Albuquerque, NM. The survey did not query personal use, but rather asked whether respondents knew of other students who used specific OTC medicines to "get high." Nine of the 16 OTC medications listed contain DM (Table 1). Muriatic acid and DM were also listed to discern whether young people were familiar with the ingredients independent of the OTCs that contain them. Two fictitious drug names (Supressin, Nalpar) were added to the list to detect false-positive response patterns. Sixty surveys were rejected based on the endorsement of 1 or both of the 2 false items, and 1 survey was rejected for reporting implausible demographics, leaving 315 valid surveys for analysis.


View this table:
[in this window]
[in a new window]
Reported Abuse of Over-the-Counter Medications by Youth


Over-the-counter drugs containing DM ranked significantly higher in selection than those without DM (t1,314 = 5.86; P<.001). Most frequently identified as an abused OTC (46.6% of high school students) was Nyquil (Proctor & Gamble, Cincinnati, Ohio) (containing both DM and alcohol), and 6 of the 7 OTC medications most frequently selected (>15%) contained DM. Reported abuse of DM increased with student age (r = 0.23, P<.01). Selection of DM and muriatic acid was relatively low (6.2% and 12.9%, respectively).

Consistent with our findings, laboratory investigations using adult humans indicate that DM produces subjective experiences that are very similar to the effects of other popular drugs of abuse (barbiturates, LSD, and PCP).5 Bem and Peck6 documented 64 spontaneous reports of DM dependence that are inconsistent with prior reports that have concluded that DM has no addictive properties. Other studies have found that DM can produce serious behavioral and central nervous system effects (including behavioral stereotypies, epileptic seizures, and death) that are related to the dose and frequency of administration.7 In patients with epilepsy, DM has been found to significantly increase the frequency of complex partial seizures at very low antitussive doses, further corroborating laboratory data.7-8 This evidence suggests that DM is an OTC drug with a more serious abuse potential than is generally realized or reported in the literature, and its accessibility may make it particularly attractive to youth.

W. Craig Noonan, PhD; William R. Miller, PhD; Dennis M. Feeney, PhD
Department of Psychology
The University of New Mexico
Albuquerque, NM 87131-1161

1. Cranston JW, Yoast R. Abuse of dextromethorphan. Arch Fam Med. 1999;8:99-100. FREE FULL TEXT
2. McFee RB, Mofenson HC, Caraccio TR. Dextromethorphan: another "ecstasy"? Arch Fam Med. 2000;9:123. FREE FULL TEXT
3. McCarthy JP. Some less familiar drugs of abuse. Med J Aust. 1971;20:1078-1081.
4. Murray S, Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. South Med J. 1993;86:1151-1153. FULL TEXT | ISI | PUBMED
5. Jasinski DR, Martin WR, Mansky PA. Progress Report on the Assessment of the Antagonists Nalbuphine and GPA-2087 for Abuse Potential and Studies of the Effects of Dextromethorphan in Man. Bethesda, Md; NIMH Addiction Research Center, Committee on Problems of Drug Dependence; 1971:143-178.
6. Bem JL, Peck R. Dextromethorphan: an overview of safety issues. Drug Saf. 1992;7:190-199. ISI | PUBMED
7. Fisher RS, Cysyk BJ, Lesser RP, Hart JL, Schwerdt O, Gordon B. Dextromethorphan for treatment of complex partial seizures. Neurology. 1990;40:547-549. FREE FULL TEXT
8. Takazawa A, Anderson P, Abraham WC. Effects of dextromethorphan, a nonopioid antitussive, on development and expression of amygdaloid kindled seizures. Epilepsia. 1990;31:496-502. PUBMED

Arch Fam Med. 2000;9:791-792.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Paul et al.
Arch Pediatr Adolesc Med 2007;161:1140-1146.
ABSTRACT | FULL TEXT  

Adolescent Abuse of Dextromethorphan
Schwartz
CLIN PEDIATR 2005;44:565-568.
ABSTRACT  

Effect of Dextromethorphan, Diphenhydramine, and Placebo on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Paul et al.
Pediatrics 2004;114:e85-e90.
ABSTRACT | FULL TEXT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.